Glycogen storage disease type I CT
|
Glycogen storage disease type I Microchapters |
|
Differentiating Glycogen storage disease type I from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type I CT On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type I CT |
|
Directions to Hospitals Treating Glycogen storage disease type I |
|
Risk calculators and risk factors for Glycogen storage disease type I CT |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Abdominal computed tomography or magnetic resonance imaging with contrast is performed to screen for hepatocellular carcinoma and should be repeated every 6 - 12 months or earlier on the basis of laboratory and clinical findings.
CT
- Abdominal computed tomography or magnetic resonance imaging with contrast is performed to screen for hepatocellular carcinoma in patients including:[1]
- Pediatric age group once adenoma is detected on ultrasound
- Older patients even if there is no adenoma on ultrasound
- These investigations should be repeated every 6 - 12 months or earlier on the basis of laboratory and clinical findings.
References
- ↑ Kishnani, Priya S.; Austin, Stephanie L.; Abdenur, Jose E.; Arn, Pamela; Bali, Deeksha S.; Boney, Anne; Chung, Wendy K.; Dagli, Aditi I.; Dale, David; Koeberl, Dwight; Somers, Michael J.; Burns Wechsler, Stephanie; Weinstein, David A.; Wolfsdorf, Joseph I.; Watson, Michael S. (2014). "Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics". Genetics in Medicine. doi:10.1038/gim.2014.128. ISSN 1098-3600.